Merck gains approval of HIV drug regimen Idvynso
Summary
FDA approves Merck’s Idvynso single-pill HIV regimen containing doravirine and islatravir. Read more here.
Description
FDA approves Merck’s Idvynso single-pill HIV regimen containing doravirine and islatravir. Read more here.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source